Gordon, Aubree L
- St. Jude Children's Research Hospital (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #765
- Sustained Excellence
- Program Leader
- Top 5% Funded
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$4.9M
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#765
By linked amount among FY2023 PIs
Earliest Year Loaded
2011
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Gordon, Aubree L as a PI. Multi-PI records show the full award amount for context.
- 5U01AI144616-05U01Contact PIDIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity$4.9Maward amount
Award organization
Organizations that administered FY2023 awards listing Gordon, Aubree L as a PI.
FY2023 award administered by St. Jude Children's Research Hospital (TN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardSt. Jude Children's Research Hospital
- 2011$500K Cumulative Funding
- 2012$1M Cumulative Funding
- 2014$2M Cumulative Funding
- 2019$5M Cumulative Funding
- 2019Entered Top 50% NationallyRanked #642
- 2019Entered Top 25% NationallyRanked #642
- 2019Entered Top 10% NationallyRanked #642
- 2019Entered Top 5% NationallyRanked #642
- 2019Program/Center Grant Leader
- 2020$10M Cumulative Funding
- 2020Entered Top 1% NationallyRanked #176
- 2022$25M Cumulative Funding